Kam Sprott

Kam Sprott is an experienced professional in the field of translational medicine and biotechnology. Currently serving as Executive Director of Translational Medicine at Deciphera Pharmaceuticals since January 2020, Kam has previously held significant roles such as Senior Director of Translational Sciences at Verastem Oncology from February 2013 to January 2020, and has provided consultancy services in various capacities for companies including X4 Pharmaceuticals, Infinity Pharmaceuticals, and Sprott Biotech Consulting, LLC, which Kam founded. Additional experience includes a position as Sr. Director of Product Development and Molecular Characterization at On-Q-ity and Development Scientist at Cell Signaling Technology. Kam holds a Ph.D. in Molecular Biosciences from The University of Kansas, earned from 1996 to 2001.